Concord Medical Services Holdings EBITDA Margin 2010-2024 | CCM
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Concord Medical Services Holdings (CCM) over the last 10 years. The current EBITDA margin for Concord Medical Services Holdings as of June 30, 2024 is .
Concord Medical Services Holdings EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2016-03-31 |
$0.09B |
$-0.01B |
-5.43% |
2015-12-31 |
$0.10B |
$0.00B |
1.03% |
2015-09-30 |
$0.10B |
$0.07B |
67.65% |
2015-06-30 |
$0.12B |
$0.08B |
64.46% |
2015-03-31 |
$0.14B |
$0.09B |
61.15% |
2014-12-31 |
$0.16B |
$0.09B |
55.77% |
2014-09-30 |
$0.18B |
$0.03B |
18.08% |
2014-06-30 |
$0.17B |
$0.03B |
17.44% |
2014-03-31 |
$0.17B |
$0.03B |
16.77% |
2013-12-31 |
$0.16B |
$0.03B |
16.98% |
2013-09-30 |
$0.15B |
$0.03B |
19.59% |
2013-06-30 |
$0.14B |
$0.03B |
21.68% |
2013-03-31 |
$0.12B |
$0.03B |
26.02% |
2012-12-31 |
$0.11B |
$0.03B |
30.84% |
2012-09-30 |
$0.09B |
$0.02B |
24.72% |
2012-06-30 |
$0.08B |
$0.02B |
28.95% |
2012-03-31 |
$0.07B |
$0.02B |
29.73% |
2011-12-31 |
$0.07B |
$0.02B |
30.00% |
2011-09-30 |
$0.07B |
$0.03B |
43.48% |
2011-06-30 |
$0.06B |
$0.03B |
43.75% |
2011-03-31 |
$0.06B |
$0.03B |
43.33% |
2010-12-31 |
$0.06B |
$0.03B |
44.83% |
2010-09-30 |
$0.05B |
$0.03B |
59.26% |
2010-06-30 |
$0.05B |
$0.04B |
72.00% |
2010-03-31 |
$0.05B |
$0.04B |
86.96% |
2009-12-31 |
$0.04B |
$0.04B |
100.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Nursing Homes |
$0.019B |
$0.076B |
Concord Medical Services Holdings Limited operates a large network of radiotherapy and diagnostic imaging centers in China. Most of the centers in their network are established through long-term lease and management services arrangements entered into with their hospital partners. Under these arrangements, Concord Medical receives a contracted percentage of each center's revenue net of specified operating expenses. Each center is located on the premises of their hospital partners and is typically equipped with a primary unit of advanced radiotherapy or diagnostic imaging equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, PET-CT scanner or MRI scanner.
|